These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 31278301
1. Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes. Koedoot E, Fokkelman M, Rogkoti VM, Smid M, van de Sandt I, de Bont H, Pont C, Klip JE, Wink S, Timmermans MA, Wiemer EAC, Stoilov P, Foekens JA, Le Dévédec SE, Martens JWM, van de Water B. Nat Commun; 2019 Jul 05; 10(1):2983. PubMed ID: 31278301 [Abstract] [Full Text] [Related]
2. Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis. Wang Z, Li Y, Xiao Y, Lin HP, Yang P, Humphries B, Gao T, Yang C. Int J Cancer; 2019 Nov 15; 145(10):2767-2780. PubMed ID: 31008533 [Abstract] [Full Text] [Related]
3. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells. Rigiracciolo DC, Santolla MF, Lappano R, Vivacqua A, Cirillo F, Galli GR, Talia M, Muglia L, Pellegrino M, Nohata N, Di Martino MT, Maggiolini M. J Exp Clin Cancer Res; 2019 Feb 06; 38(1):58. PubMed ID: 30728047 [Abstract] [Full Text] [Related]
4. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Kren BT, Unger GM, Abedin MJ, Vogel RI, Henzler CM, Ahmed K, Trembley JH. Breast Cancer Res; 2015 Feb 06; 17():19. PubMed ID: 25837326 [Abstract] [Full Text] [Related]
5. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling. Jiang HL, Sun HF, Gao SP, Li LD, Hu X, Wu J, Jin W. Oncotarget; 2015 Jun 30; 6(18):16352-65. PubMed ID: 25970785 [Abstract] [Full Text] [Related]
6. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer. Song H, Wu T, Xie D, Li D, Hua K, Hu J, Fang L. Cell Physiol Biochem; 2018 Jun 30; 48(5):1968-1982. PubMed ID: 30092563 [Abstract] [Full Text] [Related]
7. SCD1 activity promotes cell migration via a PLD-mTOR pathway in the MDA-MB-231 triple-negative breast cancer cell line. Lingrand M, Lalonde S, Jutras-Carignan A, Bergeron KF, Rassart E, Mounier C. Breast Cancer; 2020 Jul 30; 27(4):594-606. PubMed ID: 31993937 [Abstract] [Full Text] [Related]
8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA, Huang WC, Lee WH, Wu A, Wang LS, Hsiao M, Yeh CT, Chao TY. BMC Cancer; 2016 Feb 25; 16():160. PubMed ID: 26917489 [Abstract] [Full Text] [Related]
9. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles. Kannan A, Philley JV, Hertweck KL, Ndetan H, Singh KP, Sivakumar S, Wells RB, Vadlamudi RK, Dasgupta S. Sci Rep; 2019 Aug 12; 9(1):11632. PubMed ID: 31406142 [Abstract] [Full Text] [Related]
10. USP2 promotes cell migration and invasion in triple negative breast cancer cell lines. Qu Q, Mao Y, Xiao G, Fei X, Wang J, Zhang Y, Liu J, Cheng G, Chen X, Wang J, Shen K. Tumour Biol; 2015 Jul 12; 36(7):5415-23. PubMed ID: 25687182 [Abstract] [Full Text] [Related]
11. miR-93 inhibits the invasive potential of triple-negative breast cancer cells in vitro via protein kinase WNK1. Shyamasundar S, Lim JP, Bay BH. Int J Oncol; 2016 Dec 12; 49(6):2629-2636. PubMed ID: 27840899 [Abstract] [Full Text] [Related]
12. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation. Al-Marsoummi S, Vomhof-DeKrey E, Basson MD. Cell Physiol Biochem; 2019 Dec 12; 53(6):999-1014. PubMed ID: 31838790 [Abstract] [Full Text] [Related]
13. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers. De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N. Oncotarget; 2017 Jan 10; 8(2):3072-3103. PubMed ID: 27902969 [Abstract] [Full Text] [Related]
14. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC, Wang JX, Han ML, Zhang LP, Li L. Cell Oncol (Dordr); 2017 Apr 10; 40(2):157-166. PubMed ID: 28054302 [Abstract] [Full Text] [Related]
15. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant. van Roosmalen W, Le Dévédec SE, Golani O, Smid M, Pulyakhina I, Timmermans AM, Look MP, Zi D, Pont C, de Graauw M, Naffar-Abu-Amara S, Kirsanova C, Rustici G, Hoen PA, Martens JW, Foekens JA, Geiger B, van de Water B. J Clin Invest; 2015 Apr 10; 125(4):1648-64. PubMed ID: 25774502 [Abstract] [Full Text] [Related]
16. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer. Tsai YF, Tseng LM, Hsu CY, Yang MH, Chiu JH, Shyr YM. PLoS One; 2017 Apr 10; 12(6):e0178173. PubMed ID: 28604807 [Abstract] [Full Text] [Related]
17. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers. De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N. Oncotarget; 2016 Jul 12; 7(28):43124-43149. PubMed ID: 27281609 [Abstract] [Full Text] [Related]
18. CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer. Black JL, Harrell JC, Leisner TM, Fellmeth MJ, George SD, Reinhold D, Baker NM, Jones CD, Der CJ, Perou CM, Parise LV. Breast Cancer Res Treat; 2015 Jul 12; 152(2):337-46. PubMed ID: 26105795 [Abstract] [Full Text] [Related]
19. Regulation of Yki/Yap subcellular localization and Hpo signaling by a nuclear kinase PRP4K. Cho YS, Zhu J, Li S, Wang B, Han Y, Jiang J. Nat Commun; 2018 Apr 25; 9(1):1657. PubMed ID: 29695716 [Abstract] [Full Text] [Related]
20. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y, Li L. Oncotarget; 2017 Mar 21; 8(12):19455-19466. PubMed ID: 28038450 [Abstract] [Full Text] [Related] Page: [Next] [New Search]